We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Saturday
May 16
16:15 - 16:45
Poster Area
CNS malignancies
Poster Highlights
Clinical
Radiation-Induced Optic Neuropathy Following Proton Therapy for Skull Base, and Head and Neck Tumors: A Systematic Review and Meta-Analysis
Tiuri Kroese, Switzerland
-304
Biomaterial changes after re-irradiation of recurrent glioblastoma – early results of the prospective “ALA-RDT in GBM” phase I/II trial (NCT05590689)
Niklas Benedikt Pepper, Germany
-4437
Visual Outcome and Dose Tolerance of the Optic Apparatus in Fractionated Radiotherapy for Sphenoid Wing and Optic Sheath Meningiomas
Diana-Coralia Dehelean, Germany
-4708
CTRI/2025/03/082053: Targeting Chemoradiotherapy Resistance in High Grade Gliomas Using Mycophenolate Mofetil-Interim Feasibility Results
Kalyani Nair, India
-1820
Glioblastoma Tumour Dynamics During Chemoradiation on the 1.5T Magnetic Resonance Imaging-Linear Accelerator
Sweet Ping Ng, Australia
-1956
Decision regret after treatment of brain tumor – first insights from a bicentric exploratory study
Clemens Seidel, Germany
-2632
A Risk Stratification Approach to Screening for Hypopituitarism Based on Pituitary Radiation Dose in Adult Survivors of non-pituitary Brain Tumours
Liam O'Connell, Ireland
-3468
Is there consensus in contouring for SRS indications? Results from a national radiotherapy quality assurance program
Patricia Diez, United Kingdom
-3865
Reduced Planning Margins in WHO Grade III Gliomas: Patterns of Failure and Survival from a Single-Center Cohort
Jerome Nouvel, Germany
-4374
Pushing therapeutic boundaries: carbon ion re-irradiation for recurrent meningiomas after previous high-dose photon radiotherapy.
Maximilian Deng, Germany
-4409